Estimated Revenue: $10M to $50M
Last Funding Date: 2022-09-14
Investors Number: 16.0
Industry: End-to-End Drug Development
Funding Status: IPO
Technology: Biotechnology, Health Care, Therapeutics
Employee Number: 101-250
Headquarters: South San Francisco, California, United States
Last Funding Type: Post-IPO Equity
Total Funding: 306100000.0
Founded Date: 2015-01-01